MAP2K7 and hepatocellular carcinoma: These results strongly suggest that the pharmacological inhibition of MKK7-TIPRL interaction is responsible for the effect of TIPRL gene knockdown on TRAIL sensitization, which is a promising strategy to overcome TRAIL resistance in HCC.